Correlation Between Eliem Therapeutics and Viracta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Viracta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Viracta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Viracta Therapeutics, you can compare the effects of market volatilities on Eliem Therapeutics and Viracta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Viracta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Viracta Therapeutics.
Diversification Opportunities for Eliem Therapeutics and Viracta Therapeutics
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eliem and Viracta is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Viracta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viracta Therapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Viracta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viracta Therapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Viracta Therapeutics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Viracta Therapeutics
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.98 times more return on investment than Viracta Therapeutics. However, Eliem Therapeutics is 1.02 times less risky than Viracta Therapeutics. It trades about -0.21 of its potential returns per unit of risk. Viracta Therapeutics is currently generating about -0.31 per unit of risk. If you would invest 383.00 in Eliem Therapeutics on September 1, 2024 and sell it today you would lose (79.00) from holding Eliem Therapeutics or give up 20.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.24% |
| Values | Daily Returns |
Eliem Therapeutics vs. Viracta Therapeutics
Performance |
| Timeline |
| Eliem Therapeutics |
| Viracta Therapeutics |
Eliem Therapeutics and Viracta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Viracta Therapeutics
The main advantage of trading using opposite Eliem Therapeutics and Viracta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Viracta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viracta Therapeutics will offset losses from the drop in Viracta Therapeutics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Viracta Therapeutics vs. Tff Pharmaceuticals | Viracta Therapeutics vs. Eliem Therapeutics | Viracta Therapeutics vs. Inhibrx | Viracta Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world |